As many as 100,620 doses of Pfizer vaccines produced in the US arrived in Kathmandu today morning, as per the US Embassy in Kathmandu.
The US embassy made the announcement through twitter on Sunday. “The United States is donating 100,620 Pfizer vaccines to the people of Nepal, the arrival is expected tomorrow,” reads the tweet.
Before this, the US had donated 1.53 million doses of Johnson & Johnson vaccines to Nepal.
As of Sunday, 8,606,988 Nepalis have received at least one dose of anti-COVID vaccine, which is 28.3 per cent of the total population.
Similarly, 6,604,173 people have received both the doses which is nearly 22 per cent of the country’s population. The inoculated population, however is 43 per cent of the total targeted population which is the population above 18 years old.
Nepal has been using COVID vaccines manufactured by various companies given by donor countries under the COVAX programme besides the purchased ones from China and India. Until now, Nepal has been using vaccines developed by University of Oxford and pharmaceutical giant AstraZeneca manufactured in India, Japan and the UK.
Similarly, Vero Cell vaccine developed by China’s state-affiliated Sinopharm, and Johnson & Johnson’s single-shot vaccine developed in the US are also being administered.
Nepal’s recovery rate currently stands at 97.3 per cent, active case stands at 1.53 per cent and death rate is 1.4 per cent.
In the first week of September, the Ministry of Health and Population, through a study, had unveiled that around 69 per cent of the population of the country had already developed COVID-19 antibodies. The antibodies are formed after receiving COVID vaccine or once a COVID patient recovers from the disease.
The Pfizer vaccine, jointly developed by American company Pfizer and German company Biontech, is said to be effective for people above 12 years of age, according to the US Center for Disease Control. Research has confirmed that the vaccine, which requires two doses over a period of one month, is 95 percent effective.
Spokesperson of the Ministry of Health, Krishna Prasad Poudel, said that the vaccine would be first given to elderlies suffering from chronic illnesses. The government is preparing to secure an additional 6 million dose of Pfizer vaccine from the United States in December. The vaccines will be given to children above 12 years of age.